Advertisement
Advertisement
CLDX
Celldex Therapeutics, Inc
33.78
USDSponsored
+0.80
+2.43%
Jun 24, 16:00 UTC -4
Closed
After-Market
33.77
-0.01
-0.01%
CLDX Earnings Reports
Positive Surprise Ratio
CLDX beat 28 of 41 last estimates.
68%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$973.53K
/-$1.08
Implied change from Q1 26 (Revenue/ EPS)
+6390.19%
/-8.47%
Implied change from Q2 25 (Revenue/ EPS)
+33.36%
/+27.06%
Celldex Therapeutics, Inc earnings per share and revenue
On May 07, 2026, CLDX reported earnings of -1.18 USD per share (EPS) for Q1 26, missing the estimate of -1.16 USD, resulting in a -1.58% surprise. Revenue reached 15.00 thousand, compared to an expected 991.66 thousand, with a -98.49% difference. The market reacted with a +1.95% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -1.08 USD, with revenue projected to reach 973.53 thousand USD, implying an decrease of -8.47% EPS, and increase of 6390.19% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Celldex Therapeutics, Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Celldex Therapeutics, Inc reported EPS of -$1.18, missing estimates by -1.58%, and revenue of $15.00K, -98.49% below expectations.
How did the market react to Celldex Therapeutics, Inc's Q1 2026 earnings?
The stock price moved up 1.95%, changed from $33.32 before the earnings release to $33.97 the day after.
When is Celldex Therapeutics, Inc expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Celldex Therapeutics, Inc's next earnings report?
Based on 10
analysts, Celldex Therapeutics, Inc is expected to report EPS of -$1.08 and revenue of $973.53K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement